OFFICIAL DEX-CSDH WEBSITE

(DEXamethasone in Chronic SubDural Haematoma)

A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma



CURRENT RECRUITMENT
Recruitment started on the 12th August 2015, with a target of 750 patients by March 2019. We are well on target but currently performing an interim analysis for the final sample size, which could increase to a maximum of 1000 patients...watch this space for an update